Sakineh Kazemi Noureini
Overview
Explore the profile of Sakineh Kazemi Noureini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
3065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehrdad S, Cucchiarini A, Mergny J, Kazemi Noureini S
Biochimie
. 2024 May;
225:146-155.
PMID: 38821199
The industrial world exposes living organisms to a variety of metal pollutants. Here we investigated whether such elements affect G-rich sequences susceptible to fold into G-quadruplex (GQ) structures. Thermal stability...
2.
Fazelifar P, Cucchiarini A, Khoshbin Z, Mergny J, Kazemi Noureini S
J Biomol Struct Dyn
. 2023 Dec;
43(4):1674-1688.
PMID: 38100552
G-rich sequences have the potential to fold into G-quadruplexes (GQs). G-quadruplexes, particularly those positioned in the regulatory regions of proto-oncogenes, have recently garnered attention in anti-cancer drug design. A thermal...
3.
Shahpouri P, Mehralitabar H, Kheirabadi M, Kazemi Noureini S
J Biomol Struct Dyn
. 2023 Sep;
42(17):9184-9200.
PMID: 37667877
Human MRP1 protein plays a vital role in cancer multidrug resistance. Coumarins show promising pharmacological properties. Virtual screening, ADMET, molecular docking and molecular dynamics (MD) simulations were utilized as pharmacoinformatic...
4.
Vafabakhsh M, Dadmehr M, Kazemi Noureini S, Eshaghi Z, Malekkiani M, Hosseini M
Spectrochim Acta A Mol Biomol Spectrosc
. 2023 Jun;
301:122980.
PMID: 37295377
Corona Virus Disease 2019 (COVID-19) as the infectious disease caused the pandemic disease around the world through infection by SARS-CoV-2 virus. The common diagnosis approach is Quantitative RT-PCR (qRT-PCR) which...
5.
Dadkhah A, Fatemi F, Malayeri M, Ashtiyani M, Kazemi Noureini S, Rasooli A
Turk J Pharm Sci
. 2020 May;
16(4):416-424.
PMID: 32454744
Objectives: Sepsis is a clinical illness with a high rate of mortality all over the world. Oxidative stress is considered the main phenomenon that occurs in sepsis. Mill. is an...
6.
Rouhi F, Mohammadpour Z, Kazemi Noureini S, Abbastabar H, Harirchian M, Bitarafan S
Eur J Clin Pharmacol
. 2020 Feb;
76(5):611-622.
PMID: 32020320
Purpose: Although studies have shown the efficacy of laquinimod (LAQ) on disease progression in patients with multiple sclerosis (MS), there is some controversy about whether it improves the types of...
7.
Kazemi Noureini S, Fatemi L, Wink M
PLoS One
. 2018 Oct;
13(10):e0204901.
PMID: 30281650
Telomeres, the specialized dynamic structures at chromosome ends, regularly shrink with every replication. Thus, they function as an internal molecular clock counting down the number of cell divisions. However, most...
8.
Behboudi H, Kazemi Noureini S, Ghazanfari T, Ardestani S
Int Immunopharmacol
. 2018 May;
61:37-44.
PMID: 29803135
Sulfur mustard (SM) is a vesicant chemical warfare agent, and a very potent alkylating agent. SM exerts its cytotoxicity via direct alkylation of biomacromolecules, and overproduction of reactive oxygen species...
9.
Kazemi Noureini S, Kheirabadi M, Masoumi F, Khosrogerdi F, Zarei Y, Suarez-Rozas C, et al.
Int J Mol Sci
. 2018 Apr;
19(4).
PMID: 29671783
Telomerase, the enzyme responsible for cell immortality, is an important target in anti-cancer drug discovery. Boldine, an abundant aporphine alkaloid of , is known to inhibit telomerase at non-toxic concentrations....
10.
Kazemi Noureini S, Esmaeili H, Abachi F, Khiali S, Islam B, Kuta M, et al.
Biochim Biophys Acta Gen Subj
. 2017 May;
1861(8):2020-2030.
PMID: 28479277
Background: Natural bioproducts are invaluable resources in drug discovery. Isoquinoline alkaloids of Chelidonium majus constitute a structurally diverse family of natural products that are of great interest, one of them...